DOI: 10.2337/dc07-zb02 © 2007 by the American Diabetes Association
Prevention of Cardiovascular DiseaseZachary T. Bloomgarden, MD, is a practicing endocrinologist in New York, New York, and is affiliated with the Division of Endocrinology, Mount Sinai School of Medicine, New York, New York ABSTRACT Perspectives on the News commentaries are now part of a new, free monthly CME activity. The Mount Sinai School of Medicine, New York, New York, is designating this activity for 2.0 AMA PRA Category 1 credits. If you wish to participate, review this article and visit www.diabetes.procampus.net to complete a posttest and receive a certificate. The Mount Sinai School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Abbreviations: ADA, American Diabetes Association ATP, Adult Treatment Panel CETP, cholesterol ester transfer protein CHD, coronary heart disease CVD, cardiovascular disease FFA, free fatty acid FIELD, Fenofibrate Intervention and Event Lowering in Diabetes HOMA, homeostasis model assessment IFG, impaired fasting glucose NT-proBNP, NH2-terminal pro-brain natriuretic peptide PPAR, peroxisome proliferatoractivated receptor PROactive, PROspective pioglitAzone Clinical Trial in macroVascular Events TZD, thiazolidinedione UKPDS, UK Prospective Diabetes Study VAHIT, Veterans Affairs High-Density Lipoprotein Intervention Trial
|
|
|
|||||||||||||||||||||||||||